Frost & Sullivan executives have been invited to attend the 2026 6th China Medical Digital Marketing Forum, providing an in-depth analysis of the new ecosystem and development trends in medical health digital marketing enabled by AI.

Mao Hua, Senior Partner and Managing Director of Frost & Sullivan China, was invited to attend and delivered a speech on the theme "Release and Interpretation of the '2026 China Medical Health Digital Marketing White Paper'".

Mr. Mao Hua pointed out that the core of medical health digital marketing lies in providing continuous, reliable information and services to assist the audience in understanding products and supporting subsequent conversion actions such as consultation and medication purchase. The digital marketing journey constitutes an operational closed loop comprising four key stages: information collection, content generation, compliance review, and content distribution and behavior feedback. For different types of audiences, marketing strategies exhibit significant dual-track characteristics: for doctors and medical professionals (HCPs), the focus is on "professional reach" and "content support," namely achieving precise reach based on department, professional title, and academic interests, and systematically delivering academic content such as literature, guidelines, and case studies; for patients, it emphasizes "journey coverage" across the entire chain, spanning from disease awareness, consultation, medication purchase to subsequent management, and deepening trust through evidence-based content and experience delivery, and realizing long-term patient operations via follow-up visits, monitoring, and medication reminders. The industry platform fully empowers content operation with a data foundation and professional capabilities, enabling comprehensive connection between information delivery and ongoing management for different audiences.

Mr. Mao Hua further analyzed that, in the scenario-based approach to digital marketing, different product categories differ in professional requirements and user decision-making paths and thus require differentiated applications. For multi-dimensional product categories such as innovative drugs, OTC, medical devices, senior health, and nutrition, digital marketing must establish a replicable standardized SOP "standard capability pool," deeply embedding user insight, content, compliance, and operation capabilities. On top of the standard capability pool, reusable modules can be identified and recombined according to category characteristics to enable differentiated applications; for example, innovative drugs focus on scientific basis and usage education, medical devices focus on device monitoring, and senior health focuses on elderly-friendly services and family coordination, thereby enabling precise population segmentation and scenario-based drug selection.

Mr. Mao Hua noted that the differentiation of audience needs and the diversity of platform capabilities are reshaping the digital marketing platform ecosystem. Doctors and medical professionals focus on accessing evidence-based information, while patients and consumers prioritize professional consultation and service access. This need differentiation drives various platforms, relying on their own resources, to establish distinct business positions, including professional academic and medical service platforms, health content and consumer decision-making platforms, and instant service and experience delivery platforms. Currently, service scenarios are continuously integrating, and health content dissemination is gradually linked closely to professional consultation, pharmaceutical trading, and health management. Comprehensive service platforms represented by JD Health, leveraging doctors, pharmacists, and AI service capabilities, and utilizing the advantages of the pharmaceutical supply chain and online and offline services, have successfully connected professional content, medical services, transaction execution, and ongoing health management, covering the diverse service needs of patients and consumers.

Mr. Mao Hua further stated that AI empowerment is driving a full-chain capability leap in medical health digital marketing. At the content production level, AI assists in generating initial popular science drafts based on authoritative sources such as clinical guidelines, and intelligent compliance pre-screening aids manual preliminary screening of key statements, achieving improved efficiency and quality and reduced risks. At the reach and interaction level, it identifies the user’s health decision-making stage based on behavior data such as search and consultation, pushes academic updates to doctors, and matches scenario-based popular science to patients, enabling stratified, precise reach. At the service conversion level, the AI health assistant and intelligent pharmacist handle professional consultation, and, in conjunction with health record data, support the long-term medication adherence management of patients with chronic diseases, forming a closed-loop connection. Meanwhile, it clarifies compliance boundaries: AI services are positioned as auxiliary tools for professionals and do not replace doctors’ diagnosis and treatment.

Medical health digital marketing is evolving comprehensively toward standardization, intelligence, platformization, and ecosystemization. The standardization dimension requires deeply integrating medical professional review, risk identification, and process documentation into the entire process of content production, dissemination, and service delivery, establishing a solid compliance foundation. The intelligence dimension is driving AI applications to transition from basic information retrieval and content assistance to higher-level Agent intelligent application, thereby supporting more continuous user communication and health services. The platformization dimension enables the further embedding of underlying common capabilities into standard modules, enhancing overall operational efficiency and service consistency. In the ecosystemization dimension, digital marketing is accelerating the breaking of service silos and gradually achieving the close connection of various service components. By comprehensively linking disease awareness, professional consultation, drug supply, payment guarantee, transaction execution, and long-term health management across the entire chain, digital marketing is promoting the extension of medical health services to multi-scenario collaboration and continuous management, thereby building a large-scale health service ecosystem that links medical institutions, medical device companies, and insurance service agencies.